Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 1999 Mar 9;160(5):649-55.

Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal

A M Holbrook  1 , R Crowther, A Lotter, C Cheng, D King
Affiliations
Meta-Analysis

Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal

A M Holbrook et al. CMAJ. .

Abstract

Objective: To analyse the evidence for the efficacy and potential harmful effects of benzodiazepines compared with other therapies in the treatment of acute alcohol withdrawal.

Data sources: MEDLINE and the Cochrane Controlled Trials Registry were searched for English-language articles published from 1966 to December 1997 that described randomized controlled trials (RCTs) of benzodiazepines in the treatment of acute alcohol withdrawal. Key words included "benzodiazepines" (exploded) and "randomized controlled trial." Bibliographies of relevant articles were reviewed for additional RCTs, and manufacturers of benzodiazepines were asked to submit additional RCT reports not in the literature.

Study selection: Articles were considered for the meta-analysis if they were RCTs involving patients experiencing acute alcohol withdrawal and comparing a benzodiazepine available in Canada with placebo or an active control drug. Of the original 23 trials identified, 11 met these criteria, representing a total of 1286 patients.

Data extraction: Data were extracted regarding the participants, the setting, details of the intervention, the outcomes (including adverse effects) and the methodologic quality of the studies.

Data synthesis: The meta-analysis of benefit (therapeutic success within 2 days) showed that benzodiazepines were superior to placebo (common odds ratio [OR] 3.28, 95% confidence interval [CI] 1.30-8.28). Data on comparisons between benzodiazepines and other drugs, including beta-blockers, carbamazepine and clonidine, could not be pooled, but none of the alternative drugs was found to be clearly more beneficial than the benzodiazepines. The meta-analysis of harm revealed no significant difference between benzodiazepines and alternative drugs in terms of adverse events (common OR 0.67, 95% CI 0.34-1.32) or dropout rates (common OR 0.68, 95% CI 0.47-0.97).

Interpretation: Benzodiazepines should remain the drugs of choice for the treatment of acute alcohol withdrawal.

PubMed Disclaimer

References

    1. J Stud Alcohol. 1977 Nov;38(11):2096-108 - PubMed
    1. JAMA. 1991 Nov 6;266(17):2431-3 - PubMed
    1. J Clin Psychiatry. 1981 Apr;42(4):169-73 - PubMed
    1. Clin Pharmacol Ther. 1983 Aug;34(2):214-9 - PubMed
    1. J Int Med Res. 1983;11(4):205-11 - PubMed

Publication types